P53 in survival, death and metabolic health: a lifeguard with a licence to kill.
The DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Abstract
The function of p53 as a tumour suppressor has been attributed to its ability to promote cell death or permanently inhibit cell proliferation. However, in recent years, it has become clear that p53 can also contribute to cell survival. p53 regulates various metabolic pathways, helping to balance glycolysis and oxidative phosphorylation, limiting the production of reactive oxygen species, and contributing to the ability of cells to adapt to and survive mild metabolic stresses. Although these activities may be integrated into the tumour suppressive functions of p53, deregulation of some elements of the p53-induced response might also provide tumours with a survival advantage.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Autophagy is another cellular program that is triggered by cell stress and p53.195, 208”
From Census and evaluation of p53 target genes (2017) · cites this paper as [195]
In the citing paper
“Target genes directly regulated by p53 participate in multiple metabolic pathways.194, 195”
From Census and evaluation of p53 target genes (2017) · cites this paper as [195]
In the citing paper
“Additional signals and persistent stress can lead to sustained expression of p53 and activation of p16INK4A contributing to a long lasting cell cycle arrest (Sharpless and DePinho, 2006; Salama et al., 2014; Kruiswijk et al., 2015).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Kruiswijk et al., 2015
In the citing paper
“Second, most types of cellular stress are able to induce a p53 response, but they all use different mechanisms to activate the protein [65, 66, 67].”
From The TP53 tumor suppressor gene: From molecular biology to clinical investigations (2025) · cites this paper as [67]
In the citing paper
“p53 also promotes fatty acid oxidation by activating the expression of CPT1C, MCD and PANK1.107”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [107]
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
Induction of autophagy and inhibition of tumorigenesis by beclin 1
Liang, X. H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H., & Levine, B. (1999) · Nature · doi:10.1038/45257 · Cited by 3,347
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Self-citationBlinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
Self-citationA model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
Cited by
Items 401–500 of 1,000
Chen, S., Tjin, C. C., Gao, X., Xue, Y., Jiao, H., Zhang, R., Wu, M., He, Z., Ellman, J. A., & Ha, Y. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002486118 · Cited by 40
“Loss of p53, a tumor suppressor that is mutated in most human cancers, has been shown to render cells more susceptible to nutrient stress (28, 29) and to the antidiabetic drug metformin (30, 31).”
BackgroundZhao, Y. F., Fang, C., Jin, C., Bao, Z., Yang, G., & Jin, Y. (2021) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2021.105028 · Cited by 37
p53 m6A modulation sensitizes hepatocellular carcinoma to apatinib through apoptosis
Ke, W., Zhang, L., Zhao, X., & Lu, Z. (2022) · APOPTOSIS · doi:10.1007/s10495-022-01728-x · Cited by 35
“p53 inactivation has been reported to be directly involved in HCC development and chemotherapy resistance [9].”
BackgroundGuan, H., Zhang, W., Liu, H., Jiang, Y., Li, F., Wu, M., Waterhouse, G. I. N., Sun‐Waterhouse, D., & Li, D. (2023) · Metabolites · doi:10.3390/metabo13020229 · Cited by 35
“p53 has been described as a sensitizer and an activator of apoptosis, as it can transcriptionally activate the expressions of Bax and Bcl-2 [21].”
BackgroundInfluentialGiacomelli, C., Natali, L., Trincavelli, M. L., Daniele, S., Bertoli, A., Flamini, G., Braca, A., & Martini, C. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.02.019 · Cited by 36
The African-specific S47 polymorphism of p53 alters chemosensitivity
Basu, S., Barnoud, T., Kung, C.-P., Reiss, M., & Murphy, M. E. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1215390 · Cited by 37
Niu, N., Ye, J., Hu, Z., Zhang, J., & Wang, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087076 · Cited by 37
Reinisch, I., Michenthaler, H., Sulaj, A., Moyschewitz, E., Krstić, J., Galhuber, M., Xu, R., Riahi, Z., Wang, T., Vujić, N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45724-y · Cited by 37
“Here, we found that IF promotes adipocyte stress by activating apoptosis as a canonical downstream signalling pathway of p53 71 .”
Zheng, Y., Lei, Q., Jongejan, A., Mulder, C. L., van Daalen, S. K. M., Mastenbroek, S., Hwang, G. H., Jordan, P. W., Repping, S., & Hamer, G. (2018) · DNA repair · doi:10.1016/j.dnarep.2018.08.027 · Cited by 32
Zhao, P., Wang, H., Wang, H., Dang, Y., Luo, L., Li, S., Shi, Y., Wang, L., Wang, S., Mager, J., et al. (2019) · Epigenetics · doi:10.1080/15592294.2019.1669375 · Cited by 35
“TRP53 plays a central role in a variety of biological processes including cell cycle arrest, DNA damage repair, apoptosis and metabolic changes [49].”
BackgroundSer392 phosphorylation modulated a switch between p53 and transcriptional condensates
Dai, Z., Li, G., Chen, Q., & Yang, X. (2022) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2022.194827 · Cited by 33
Chen, L., Ahmad, N., & Liu, X. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1151582 · Cited by 35
“Recently, p53 has also been shown to regulate several energy metabolism pathways, including both glycolysis and mitochondrial respiration.(11,12) To support, activation of p53 suppresses glycolysis through directly or indirectly inhibiting the transcription of several factors that are important in the glycolytic pathw…”
BackgroundConsequences of irradiation on adult spermatogenesis: Between infertility and hereditary risk
Marjault, H., & Allemand, I. (2016) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2016.07.004 · Cited by 34
Nucleo-cytoplasmic environment modulates spatiotemporal p53 phase separation
Datta, D., Navalkar, A., Sakunthala, A., Paul, A., Patel, K. M., Masurkar, S. A., Gadhe, L. G., Manna, S., Bhattacharyya, A., Sengupta, S., et al. (2024) · Science Advances · doi:10.1126/sciadv.ads0427 · Cited by 36
Li, W., Ou, Q., Dai, H., & Liu, C. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160819419 · Cited by 31
“suppressor is the central component of a complex network of signaling pathways that protect organisms against the propagation of cells carrying oncogenic mutations [25].”
BackgroundDomostegui, A., Peddigari, S., Mercer, C. A., Iannizzotto, F., Rodríguez, M. L., Garcia‐Cajide, M., Amador, V., Diepstraten, S. T., Kelly, G. L., Salazar, R., et al. (2021) · Blood · doi:10.1182/blood.2020007452 · Cited by 36
Zhang, Y., Huang, X., Wang, L., Cao, C., Zhang, H., Wei, P., Ding, H., Song, Y., Chen, Z., Qian, J., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120720 · Cited by 31
Mechanism and Disease Association With a Ubiquitin Conjugating E2 Enzyme: UBE2L3
Zhang, X., Huo, C., Liu, Y., Su, R., Zhao, Y., & Li, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.793610 · Cited by 38
Hallmarks of cancer: The insulin-like growth factors perspective
Werner, H., & LeRoith, D. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1055589 · Cited by 33
“The p53 pathway is activated in response to different stress signals, including DNA damage and telomere shortening, hypoxia, heat and cold shock, inflammation and activation of oncogenes by mutations (105, 106).”
BackgroundFan, H., Wang, K., Zhao, X., Song, B., Yao, T., Liu, T., Gao, G., Lu, W., & Liu, C. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1335122 · Cited by 33
“It suppresses glycolysis while promoting the metabolic transition toward oxidative phosphorylation, thereby increasing the susceptibility of cells to copper-induced cell death (Kruiswijk et al., 2015).”
BackgroundResultSulphur dioxide ameliorates colitis related pathophysiology and inflammation
Banerjee, S., Ghosh, S., Sinha, K., Chowdhury, S., & Sil, P. C. (2018) · Toxicology · doi:10.1016/j.tox.2018.11.010 · Cited by 33
Streptozotocin induces renal proximal tubular injury through p53 signaling activation
Nakai, K., Umehara, M., Minamida, A., Yamauchi-Sawada, H., Sunahara, Y., Matoba, Y., Okuno-Ozeki, N., Nakamura, I., Nakata, T., Yagi-Tomita, A., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-35850-w · Cited by 40
Paeoniflorin suppresses ferroptosis after traumatic brain injury by antagonizing P53 acetylation
Zhi, S., Cui, Y., Liu, Y., Zhang, J., Li, X.-J., Sheng, B., Chen, X.-X., Yan, C., Li, W., Mao, J.-N., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155940 · Cited by 35
Effects of Vitrification on the Blastocyst Gene Expression Profile in a Porcine Model
Cuello, C., Martinez-Serrano, C. A., Cambra, J. M., Parrilla, I., Rodríguez‐Martínez, H., Gil, M. A., & Martinez, E. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031222 · Cited by 30
“Among the upregulated DEGs, the following genes included in these categories, the TP53INP (tumor protein p53 inducible nuclear protein 1) and CDKN1A (cyclin-dependent kinase inhibitor 1A (p21, Cip 1) genes, are of special interest for their role in the regulation of cell death and survival under stress conditions [22,…”
BackgroundGonzález‐Moles, M. Á., Pino, C. K.-D., & Ramos‐García, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113099 · Cited by 34
“This protein exerts its tumor suppressor functions by inducing apoptosis in cells that suffer irreparable DNA damage or by triggering DNA repair mechanisms in those cases wherein this is possible without compromising the future viability and safety of the cell [103].”
BackgroundLaskar, K., Faisal, S. M., Rauf, A., Ahmed, A., & Owais, M. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2017.02.082 · Cited by 52
Keightley, M.-C., Carradice, D., Layton, J. E., Pase, L. B., Bertrand, J. Y., Wittig, J. G., Dakic, A., Badrock, A. P., Cole, N. J., Traver, D. J., et al. (2017) · Nature Communications · doi:10.1038/ncomms14911 · Cited by 32
The Zn2+ and Ca2+‐binding S100B and S100A1 proteins: beyond the myths
Baudier, J., Deloulme, J., & Shaw, G. S. (2020) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12585 · Cited by 31
“The interplay between p53, ATAD3A and metabolism is essential in cell fate (Kruiswijk et al., 2015; Yang & Suda, 2018).”
BackgroundSynthetic lethality: A promising therapeutic strategy for hepatocellular carcinoma
Tang, L., Chen, R., & Xu, X. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.02.016 · Cited by 30
Abdel-Wahhab, M. A., El‐Nekeety, A. A., Hathout, A. S., Salman, A. S., Abdel‐Aziem, S. H., Sabry, B. A., Hassan, N. S., Abdel-aziz, M. S., Aly, S. E., & Jaswir, I. (2020) · Toxicon · doi:10.1016/j.toxicon.2020.04.103 · Cited by 30
Bi, G., Bian, Y., Liang, J., Yin, J., Li, R., Zhao, M., Huang, Y., Lu, T., Zhan, C., Fan, H. X., et al. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02889-0 · Cited by 31
“For instance, it has been widely accepted that mutated TP53 and amplified MYC are linked to several anabolic and catabolic pathways [43, 44].”
BackgroundTargeting microRNAs with thymoquinone: a new approach for cancer therapy
Homayoonfal, M., Asemi, Z., & Yousefi, B. (2021) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-021-00286-5 · Cited by 34
“cycle progression, cell death, cell proliferation inhibitors or even cell survival as well as different metabolic pathways [44].”
BackgroundPaesa, M., Nogueira, D. P., Rodríguez, G. R. V., Esparza, I., Jiménez‐Moreno, N., Mendoza, G., Osada, J., Martín‐Belloso, O., Rodriguez‐Yoldi, M. J., & Ancín‐Azpilicueta, C. (2022) · Antioxidants · doi:10.3390/antiox11040733 · Cited by 35
Cai, L., Li, D., Feng, Z., Gu, X., Xu, Q., & Li, Q. (2022) · Disease Markers · doi:10.1155/2022/3153362 · Cited by 37
Nuclear Phosphoinositides as Key Determinants of Nuclear Functions
Vidalle, M. C., Sheth, B., Fazio, A., Marvi, M. V., Leto, S., Koufi, F., Neri, I., Casalin, I., Ramazzotti, G., Follo, M. Y., et al. (2023) · Biomolecules · doi:10.3390/biom13071049 · Cited by 31
“Two tumour suppressor proteins, retinoblastoma (pRB) [187] and p53 [188], are critical for controlling how cells respond to excessive cell proliferative signals, such as those induced by oncogenes, and to DNA damage.”
Geng, Y., Zhang, C., Lei, J.-L., Yu, P., Xia, Y., Zhang, H., Yang, L., & Kong, L. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.06.134 · Cited by 31
Survivin antagonizes chemotherapy-induced cell death of colorectal cancer cells
Rauch, A., Carlstedt, A., Emmerich, C., Mustafa, A. M., Göder, A., Knauer, S. K., Linnebacher, M., Heinzel, T., & Krämer, O. H. (2018) · Oncotarget · doi:10.18632/oncotarget.25600 · Cited by 29
“com (PIG3) are pro-apoptotic transcriptional targets of p53 [10, 31, 32].”
BackgroundInfluentialMontellier, E., Lemonnier, N., Penkert, J., Freycon, C., Blanchet, S., Amadou, A., Chuffart, F., Fischer, N. W., Achatz, M.-I., Levine, A. J., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111296 · Cited by 29
Wang, K., Liu, W., Xu, Q., Gu, C., & Hu, D. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153553 · Cited by 28
A chaotic outlook on biological systems
Scharf, Y. (2016) · Chaos Solitons & Fractals · doi:10.1016/j.chaos.2016.12.013 · Cited by 29
The Cdkn1aSUPER Mouse as a Tool to Study p53-Mediated Tumor Suppression
Torgovnick, A., Heger, J., Liaki, V., Isensee, J., Schmitt, A., Knittel, G., Riabinska, A., Beleggia, F., Laurien, L., Leeser, U., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.079 · Cited by 29
Wang, H., Wang, L., Wang, Z., Dang, Y., Shi, Y., Zhao, P., & Zhang, K. (2019) · The FASEB Journal · doi:10.1096/fj.201902623r · Cited by 29
CLytA-DAAO, Free and Immobilized in Magnetic Nanoparticles, Induces Cell Death in Human Cancer Cells
Fuentes-Baile, M., Bello‐Gil, D., Pérez-Valenciano, E., Sanz, J. M., García-Morales, P., Maestro, B., Ventero, M. P., Alenda, C., Barberá, V. M., & Saceda, M. (2020) · Biomolecules · doi:10.3390/biom10020222 · Cited by 28
“TP53 is crucial in the cellular response to agents that induce DNA damage [57,58].”
Pastore, M., Lori, G., Gentilini, A., Taddei, M. L., Maira, G. D., Campani, C., Recalcati, S., Invernizzi, P., Marra, F., & Raggi, C. (2020) · Cells · doi:10.3390/cells9030596 · Cited by 28
“Indeed loss of this protein causes an increased glycolytic flux to induce anabolism and redox balance that ultimately leads to tumorigenesis [175].”
BackgroundThe transcription factors GFI1 and GFI1B as modulators of the innate and acquired immune response
Fraszczak, J., & Möröy, T. (2021) · Advances in immunology · doi:10.1016/bs.ai.2021.03.003 · Cited by 29
Cell competition and the regulative nature of early mammalian development
Nichols, J., Lima, A., & Rodríguez, T. A. (2022) · Cell stem cell · doi:10.1016/j.stem.2022.06.003 · Cited by 33
LncRNA MEG3: Potential stock for precision treatment of cardiovascular diseases
Li, Z., Gao, J., Sun, D., Jiao, Q., Ma, J., Cui, W., Lou, Y., Xu, F., Li, S., & Li, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1045501 · Cited by 32
Dynamic links between mechanical forces and metabolism shape the tumor milieu
Bertolio, R., Napoletano, F., & Sal, G. D. (2023) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2023.102218 · Cited by 30
Disrupted Binding of Cystathionine γ-Lyase to p53 Promotes Endothelial Senescence
Hu, J., Leisegang, M. S., Looso, M., Drekolia, M.-K., Wittig, J., Mettner, J., Karantanou, C., Kyselova, A., Dumbović, G., Li, X., et al. (2023) · Circulation Research · doi:10.1161/circresaha.123.323084 · Cited by 31
“p53 has been proposed to regulate cellular metabolism, in particular glycolysis, 20,21 in part, through the negative regulation of the Glut1 (glucose transporter 1; SLC2A1 [Solute carrier 2A1]).”
BackgroundRegain control of p53: Targeting leukemia stem cells by isoform-specific HDAC inhibition
Kuo, Y., Qi, J., & Cook, G. (2016) · Experimental Hematology · doi:10.1016/j.exphem.2016.02.007 · Cited by 31
“stressors including DNA damage and oncogenic events and ultimately control fundamental cell fate decisions such as cell cycle progression, apoptosis, senescence, metabolism, and autophagy [7,8].”
BackgroundOxidative stress and mitochondrial adaptive shift during pituitary tumoral growth
Sabatino, M. E., Grondona, E., Sosa, L. D. V., Mongi‐Bragato, B., Carreño, L., Juárez, V., da Silva, R. A., Remor, A. P., da Silva, L. D. B., Martins, R. D. P., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.03.019 · Cited by 28
Mi, S., Tang, Y., Dari, G., Shi, Y., Zhang, J., Zhang, H., Liu, X., Liu, Y., Usman, Τ., & Yu, Y. (2021) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-021-00639-2 · Cited by 28
“aureus, the results of the present study showed that the expression of genes within ABC transporters [62] involved with toxin secretion, MAPK signaling pathway [63] and p53 signaling pathway [64] related”
ResultAlaee, M., Danesh, G., & Pasdar, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154323 · Cited by 27
Nutlin-Induced Apoptosis Is Specified by a Translation Program Regulated by PCBP2 and DHX30
Rizzotto, D., Zaccara, S., Rossi, A., Galbraith, M. D., Andrysík, Z., Pandey, A., Sullivan, K. D., Quattrone, A., Espinosa, J. M., Dassi, E., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.03.011 · Cited by 31
Metabolic landscapes in sarcomas
MIALLOT, R., Galland, F., Millet, V., Blay, J., & Naquet, P. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01125-y · Cited by 35
Melnik, B. C., & Schmitz, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911503 · Cited by 28
Critical roles and clinical perspectives of RNA methylation in cancer
Li, G., Yao, Q., Liu, P., Zhang, H., Liu, Y., Li, S., Shi, Y., Li, Z., & Zhu, W. (2024) · MedComm · doi:10.1002/mco2.559 · Cited by 34
“259 262 Multiple studies have reported GLUT1 upregulation owing to mutations in HIF-1 α , RAS, p53, and the PI3K/AKT signaling pathway in breast cancer (BC), esophageal cancer (EC), pancreatic cancer, and colorectal cancer (CRC).”
BackgroundBhanja, P., Mishra, S., Manna, K., Saha, K. D., & Bhaumik, A. (2018) · ACS Omega · doi:10.1021/acsomega.7b01672 · Cited by 27
The impact of p53 on aristolochic acid I-induced nephrotoxicity and DNA damage in vivo and in vitro
Sborchia, M., Prez, E. G. D., Antoine, M., Bienfait, L., Indra, R., Valbuena, G. N., Phillips, D. H., Nortier, J., Stiborová, M., Keun, H. C., et al. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02578-4 · Cited by 30
Xie, Q., Sun, T., Zhang, L., Gong, M., Zhang, W., Liu, X., Zhao, Y., Wang, M., Yang, X., Zhang, Z., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122971 · Cited by 27
Ma, W., & Zhou, S. (2025) · Biomolecules · doi:10.3390/biom15020168 · Cited by 37
Rewiring cancer metabolism: oncogenic signaling pathways and targeted therapeutics
Lyu, S., Gildor, N., Zhang, Q. H., & Liao, C. (2025) · Science China Life Sciences · doi:10.1007/s11427-025-2979-3 · Cited by 30
“Accord-ingly, loss of p53 enhances glycolytic flux, fostering anabolic metabolism and redox balance — two hallmarks of tumorigenesis (Figure 1) (Kruiswijk et al., 2015).”
p53 family members — important messengers in cell death signaling in photodynamic therapy of cancer?
Acedo, P., & Zawacka‐Pankau, J. (2015) · Photochemical & Photobiological Sciences · doi:10.1039/c5pp00251f · Cited by 28
Castillo, J., Stueve, T. R., & Marconett, C. N. (2017) · Oncotarget · doi:10.18632/oncotarget.18432 · Cited by 28
“This may seem contradictory, but there have been reports of p53 mediating pro-survival pathways during DNA repair [160], such as p53 activation of p21/NRF2 signaling [161].”
BackgroundBioactive food and exercise in chronic kidney disease: Targeting the mitochondria
Mafra, D., Gidlund, E., Borges, N. A., Magliano, D. C., Lindholm, B., Stenvinkel, P., & von Walden, F. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.13020 · Cited by 28
“18,21‐23 Tumour suppressor protein p53 is known as the “guardian of the mitochondria genome” 24 and has the ability to modulate expression of both the mitochondrial and the nucleus genes.(25,26) Metabolic stress results in p53 activation by its key modulator PGC‐1α and triggers cell‐cycle arrest, reactive oxygen speci…”
BackgroundSalvation of the fallen angel: Reactivating mutant p53
Yang, L., Wang, Z., Chen, Y., Petersen, R. B., Zheng, L., & Huang, K. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14572 · Cited by 28
Modulation of cancer cell signaling by long noncoding RNAs
Mirhosseini, S. A., Sarfi, M., Tehrani, S. S., Mirazakhani, M., Maniati, M., & Amani, J. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28847 · Cited by 26
“P53 is one of the most prominent tumor suppressors that is involved in a wide range of cellular processes such as cell cycle arrest, apoptosis, and DNA damage response.(123) This vital protein, plays key roles in the regulation of different processes including cell proliferation, cell metabolism, and cell senescence.”
BackgroundSin3a regulates the developmental progression through morula‐to‐blastocyst transition via Hdacl
Zhao, P., Li, S., Wang, H., Dang, Y., Wang, L., Liu, T., Wang, S., Li, X., & Zhang, K. (2019) · The FASEB Journal · doi:10.1096/fj.201901213r · Cited by 27
“Trp53 activation is induced by stress signals, including DNA damage (38).”
BackgroundThe guardian's choice: how p53 enables context‐specific decision‐making in individual cells
Friedel, L., & Loewer, A. (2021) · FEBS Journal · doi:10.1111/febs.15767 · Cited by 32
Lu, J., Wood, D., Ingley, E., Kõks, S., & Wong, D. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06362-5 · Cited by 31
Timmerman, D. M., Remmers, T. L., Hillenius, S., & Looijenga, L. H. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105377 · Cited by 28
“P21, resulting in cell cycle arrest [74].”
BackgroundInfluentialp53-Dependent Repression: DREAM or Reality?
Peuget, S., & Selivanova, G. (2021) · Cancers · doi:10.3390/cancers13194850 · Cited by 30
Xu, J., Xiao, X., Yan, B., Yuan, Q., Dong, X., Du, Q., Zhang, J., Shan, L., Ding, Z., Zhou, L., et al. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02468-3 · Cited by 28
“As a tumor suppressor, TP53 encodes p53 transcriptional factor to prevent tumor development through permanently suppression of cell proliferation by cell cycle arrest and facilitation of cell death by apoptosis [19].”
BackgroundOrigin of Cancer: Cell work is the Key to Understanding Cancer Initiation and Progression
Hanselmann, R., & Welter, C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.787995 · Cited by 21
Sun, Y., Li, T., Xie, C., Xu, Y., Zhou, K., Rodríguez, J., Han, W., Wang, X., Kroemer, G., Modjtahedi, N., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.196 · Cited by 29
“The p53 protein regulates diverse cellular processes, including cell death, redox homeostasis, and metabolism, under both physiological and pathological conditions.(45,46) Studies have shown that p53 is involved in neonatal rat cerebral HI brain injury and that p53 translocates and accumulates in the mitochondria at 3…”
BackgroundLiu, Y., Xu, F., Wang, Y., Wu, Q., Wang, B., Yao, Y., Zhang, Y., Han‐Zhang, H., Ye, J., Zhang, L., et al. (2019) · Oncology Letters · doi:10.3892/ol.2019.10625 · Cited by 32
“Under normal conditions, TP53 is rapidly degraded; however, upon cellular stress, it is activated and stabilized, resulting in protein accumulation in the nucleus (5,6).”
BackgroundIdentification of universal and cell-type specific p53 DNA binding
Hafner, A., Kublo, L., Tsabar, M., Lahav, G., & Stewart-Ornstein, J. (2020) · BMC Molecular and Cell Biology · doi:10.1186/s12860-020-00251-8 · Cited by 25
“The role of the p53 itself in this decision making is controversial, with arguments for p53 behaving as a smart ‘signal integrator’ (reviewed in [1]) or a simple effector [11].”
Elsherbiny, N. M., Eisa, N. H., El‐Sherbiny, M., & Said, E. (2020) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2020.103494 · Cited by 28
Grandis, R. A. D., de Oliveira, K. M., Guedes, A. P. M., dos Santos, P. W. D. S., Aissa, A. F., Batista, A. A., & Pavan, F. R. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.682968 · Cited by 28
Targeting p53 in chronic lymphocytic leukemia
Moia, R., Boggione, P., Mahmoud, A. M., Kodipad, A. A., Adhinaveni, R., Sagiraju, S., Patriarca, A., & Gaïdano, G. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1832465 · Cited by 27
The Impact of dUTPase on Ribonucleotide Reductase-Induced Genome Instability in Cancer Cells
Chen, C., Tsao, N., Huang, L.-Y., Yen, Y., Liu, X., Lehman, C. E., Wang, Y.-H., Tseng, M., Chen, Y., Ho, Y.-C., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.094 · Cited by 25
An EZH2-mediated epigenetic mechanism behind p53-dependent tissue sensitivity to DNA damage
Abali, G. K., Gong, L., Yan, J., Liu, Q., Zeng, W., Williamson, A. K., Lim, C. B., Molloy, M. E., Little, J. B., Huang, L. H., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1719532115 · Cited by 29
“In line with the finding that the expression of MDM2 is primarily controlled by p53 (3, 8), the level of MDM2 is diminished in cells harboring p53 mutation.”
BackgroundRajamanickam, V., Yan, T., Wu, L., Zhao, Y., Xu, X., Zhu, H., Chen, X., Wang, M., Liu, Z., Liu, Z., et al. (2020) · Cancer Management and Research · doi:10.2147/cmar.s227415 · Cited by 26
“Increased levels of ROS may be derived through NADPH oxidases(7,8) and loss of tumor suppressor pathways altering antioxidant networks.(9) Cancer cells may utilize elevated ROS for progression, increasing the rate Correspondence: Yi Wang Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medi…”
BackgroundLoss of tRNA-modifying enzyme Elp3 activates a p53-dependent antitumor checkpoint in hematopoiesis
Rosu, A., Hachem, N. E., Rapino, F. A., Rouault‐Pierre, K., Jorssen, J., Somja, J., Ramery, E., Thiry, M., Nguyen, L., Jacquemyn, M., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20200662 · Cited by 30
Shi, Y., Ye, J., Yang, Y., Zhao, Y., Shen, H., Ye, X., & Xie, W. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.692497 · Cited by 27
p53-Dependent and -Independent Epithelial Integrity: Beyond miRNAs and Metabolic Fluctuations
Oikawa, T., Otsuka, Y., & Sabe, H. (2018) · Cancers · doi:10.3390/cancers10060162 · Cited by 24
González‐Moles, M. Á., Warnakulasuriya, S., López-Ansio, M., & Ramos‐García, P. (2022) · Cancers · doi:10.3390/cancers14153834 · Cited by 28
“This differentiation-inducing activity appears to be relevant for the exercise of p53-mediated tumour suppression [161].”
BackgroundMacha, S. J., Koneru, B., Burrow, T. A., Zhu, C., Savitski, D., Rahman, R. L., Ronaghan, C. A., Nance, J., McCoy, K., Eslinger, C. R., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0125 · Cited by 27
Celik, A., Orfany, A., Dearling, J. L. J., del Nido, P. J., McCully, J. D., & Bakar‐Ates, F. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114524 · Cited by 26
Li, J., Li, T., Li, Z., Song, Z., & Gong, X. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1154743 · Cited by 28
“p53 represents a family of tumor suppressors and is a key component of the cell’s response to stress (Kruiswijk et al., 2015; Ong and Ramasamy, 2018).”
BackgroundPermission to pass: on the role of p53 as a gatekeeper for aneuploidy
Marques, J. F., & Kops, G. J. P. L. (2023) · Chromosome Research · doi:10.1007/s10577-023-09741-9 · Cited by 28
“The various intricacies of the regulation and function of p53 have been extensively reviewed else-where (Kastenhuber and Lowe 2017; Kruiswijk et al. 2015); for the context of this review, we will briefly outline what is known about p53 activation and consequent outcomes in response to an insult.”
BackgroundRoselle, C., Horikawa, I., Chen, L., Kelly, A. R., Gonzales, D. M., Da, T., Wellhausen, N., Rommel, P. C., Baker, D., Suhoski, M. M., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2317735121 · Cited by 27
“…of intense investigation—and more publications than any gene in his-tory—have revealed that p53 is more than just the “guardian of the genome,” as it also mediates several pro - survival and pro - proliferative transcriptional programs in response to milder forms of cellular stress (18, 19).”
Metabolic, autophagic, and mitophagic activities in cancer initiation and progression
Hjelmeland, A. B., & Zhang, J. (2016) · Biomedical Journal · doi:10.1016/j.bj.2015.10.002 · Cited by 26
“[162] Kruiswijk F, Labuschagne CF, Vousden KH.”
Senescence chips for ultrahigh‐throughput isolation and removal of senescent cells
Chen, Y., Mao, P., Snijders, A. M., & Wang, D. (2018) · Aging Cell · doi:10.1111/acel.12722 · Cited by 25
Xing, Y., & Li, L. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.01.013 · Cited by 24
RetractedLucena, S. R., Zamarrón, A., Carrasco, E., Marigil, M., Mascaraque, M., Fernández-Guarino, M., Gilaberte, Y., González, S., & Juarranz, Á. (2019) · Scientific Reports · doi:10.1038/s41598-019-41313-y · Cited by 24
Huang, Y., Wang, X., Feng, Z., Cui, H., Zhu, Z., Xia, C., Han, X., Liu, W. J., & Liu, Y. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/7202519 · Cited by 27
“P53 can be activated and stabilized through posttranslational modification pathways, including ubiquitination, phosphorylation, and acetylation [10].”
BackgroundInfluentialTyagi, M., Bauri, A. K., Chattopadhyay, S., & Patro, B. S. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.01.011 · Cited by 24
Báez-Becerra, C. T., Valencia-Rincón, E., Velásquez-Méndez, K. L., Ramírez-Suárez, N. J., Guevara, C., Sandoval-Hernández, A. G., Bustos, C., Olivos-Cisneros, L., Gutiérrez‐Ospina, G., Arboleda, H., et al. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111360 · Cited by 25
Developmental Acquisition of p53 Functions
Jaiswal, S. K., Raj, S., & Depamphilis, M. (2021) · Genes · doi:10.3390/genes12111675 · Cited by 25
“Recent evidence indicates that p53 also has a role in enabling cells to adjust their metabolism in response to changes in glucose and other nutrient levels, oxygen availability, and reactive oxygen species [29,30].”
Background
Metadata
- Authors
- Kruiswijk, F., Labuschagne, C. F., & Vousden, K. H.
- Affiliations
- Cancer Research UK Scotland Institute (GB)
- Corresponding author
- Vousden, Karen H.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2015-06-23
- Volume
- 16
- Issue
- 7
- Pages
- 393-405
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1890766043
- Cited by
- 1,080
- References
- 177
- Citations by year
- 2026: 37 · 2025: 54 · 2024: 67 · 2023: 119 · 2022: 133 · 2021: 148 · 2020: 108 · 2019: 104 · 2018: 110 · 2017: 101 · 2016: 84 · 2015: 15
- FWCI
- 11.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Funders
- Cancer Research UK (C596/A10419, 18274)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- p53, tumour suppressor, cell survival, cell death, glycolysis, oxidative phosphorylation, reactive oxygen species, cancer metabolism, tumor progression
- MeSH terms
- Animals, Cell Survival, Humans, Tumor Suppressor Protein p53, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.